Health & Pharm General

Zoono Group Limited (ASX:ZNO) Signs Deal With Chinese Group Following Successful African Swine Fever Testing

🕔12/10/2019 2:25:54 PM

Zoono Group Limited (ASX:ZNO) is pleased to announce that, following six months of trials across several animal health industry sectors, a group of leaders in the Chinese agribusiness/veterinarian and animal feed sector have agreed to jointly collaborate and form a new entity to act as Zoono's exclusive distributor for the animal health and agribusiness sector in China.

Read Full Article

Cann Global Limited (ASX:CGB) Secures Global Rights to Olivias Choice Formulas

🕔12/10/2019 9:20:47 AM

Board of Cann Global Limited (ASX:CGB) is delighted to announce an agreement to secure the exclusive rights to the IP of the unique medicinal cannabis formulations that have been used by Olivia Newton John in her recent health challenge.

Read Full Article

Cann Global Limited (ASX:CGB) Operational Update

🕔12/6/2019 8:22:48 AM

Cann Global Limited (ASX:CGB) provides the following update in relation to CGB's operations of business for three of its divisions and its mining interest.

Read Full Article

Cann Global Limited (ASX:CGB) Chairperson's Address to 2019 AGM

🕔11/28/2019 2:55:41 PM

Cann Global Limited (ASX:CGB) has been achieving significant milestones in these past 12 months. The most notable being the undertaking and successful completion of a very extensive and technically comprehensive re-compliance process

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Anatara Investor Presentation and Update

🕔11/28/2019 8:30:18 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr Steven Lydeamore, will present today at the Pitt Street Research Life Sciences Conference, held in Sydney, NSW.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) R&D Tax Incentive Received

🕔11/22/2019 8:21:55 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $847,325 from the Australian Taxation Office under the Federal Government's Research and Development (R&D) tax incentive scheme.

Read Full Article

Regeneus Ltd (ASX:RGS) Chairman's Address to Shareholders and CEO AGM Presentation

🕔11/21/2019 3:15:30 PM

2019 was a productive year as we continued our aim of commercialising Progenza and Sygenus, our core regenerative medicine technology platforms. In particular, our focus has been on the lead platform, Progenza, which has shown positive results for treating osteoarthritis in its Phase 1 trials.

Read Full Article